PharmAust (ASX: PAA) has dosed the first patient of its phase 1/2 trial evaluating its lead drug monepantel (MPL) in people suffering from motor neurone disease (MND).
HSF advises OneWeb on its proposed combination with Eutelsat miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.